Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors

Veralox Therapeutics\, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs\, today announced the appointment of Alex Martin as Chairman of the Board of Directors. Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles in the life sciences indust